Total Equity Funding
Undisclosed Amount in 2 Rounds from 5 Investors
Most Recent Funding
Series A on May 1, 2015 / Undisclosed Amount
Moffett Field, California
NeuroVigil is a leading neurotechnology revolutionizing EEG analysis for clinical trials, communication and space applications.

Company Details


NeuroVigil, Inc. is a leading neurotechnology company focused on the analysis of brain signal or EEG data, which currently is used in numerous medical applications but is not automated.

NeuroVigil has three products developed to help pharmaceutical companies conduct outpatient clinical trials, ALS sufferers communicate and NASA track astronauts on the International Space Station. The company is headquartered in La Jolla and has a satellite operation at NASA Ames Research Park in Silicon Valley. The company is headed by neurotechnology pioneer and entrepreneur, Dr. Philip Low, an MIT TR-35 recipient and Jacobs-Rady Pioneer for Global Innovation and Entrepreneurship, and backed by Elon Musk and Irwin Jacobs. The company's clients include Roche and Novartis as clients and its advisors include Stephen Hawking, Stephen Wolfram and Nobel laureates Roger Guillemin and Sydney Brenner.

NeuroVigil won the DFJ and UCSD challenges and was singled out by Fast Company and The Washington Post as one of the Top 10 Most Innovative Companies in Health Care. The Company's iBrain, the world's first mobile brain monitor, won the CONNECT Most Innovative New Product in Health Care and was identified by the New York Times, as one of the "Innovations That Will Change Your Tomorrow". On May 1st 2011, NeuroVigil closed the highest valuation first round investment of any startup in history, over twice Google's and Facebook's first round valuations combined.

NeuroVigil's patented and proprietary technology provides for extremely rapid, automated, and accurate reading and interpretation of electroencephalogram data, which is a window to the functioning of the brain.The Company's technology not only automates current manual tasks, but also more than quintuples the amount of useful information obtained from current EEG data, which leads to biomarkers of drug responses, and correlates of important disease states.

Funding Rounds (2) - undisclosed

DateAmount / RoundValuationLead InvestorInvestors
May, 2015undisclosed amount / Series A5
May, 2011undisclosed amount / Seed0

Current Team (4)


Offices/Locations (1)

  • Headquarters

    NASA Research Park

    PO Box 111

    Moffett Field, California 94035-0111

    United States

Past Team (1)


Images (1)


Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos